Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

NeoRx licenses Biostent to Schwarz

April 3, 1997

Amylin acquires rights to cardiovascular agents from Hoechst Marion Roussel

April 2, 1997

Vasopressin antagonists from JT

April 2, 1997

Centocor describes peptide inhibitors of selectin binding

April 2, 1997

Endothelin antagonists from SmithKline Beecham

April 2, 1997

Wakunaga discloses angiotensin II antagonists

April 1, 1997

Armenian researchers describe novel antiarrhythmic agent

March 27, 1997

Research on cardiovascular drugs reported at the meeting of the Japanese Circulation Society

March 26, 1997

Novel positive inotrope discovered by Meiji Institute of Health Science

March 25, 1997

Terumo prepares inhibitors of smooth muscle cell proliferation

March 25, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 1, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...